Management guidelines for children with idiopathic generalized epilepsy

Epilepsia

Volumn 46, Issue SUPPL. 9, 2005, Pages 112-116

  Camfield, Carol ^a   Camfield, Peter ^a  

^a IWK HEALTH CENTRE   (Canada)

Author keywords

Antiepileptic drugs; Childhood absence epilepsy; Idiopathic generalized epilepsy; Juvenile absence epilepsy; Juvenile myoclonic epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; ASPARTAME; CARBAMAZEPINE; CLOBAZAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; SUCROSE; TOPIRAMATE; VALPROIC ACID;

ABSENCE; ACCIDENT; BENIGN CHILDHOOD EPILEPSY; CHILD; CHILD CARE; COGNITIVE DEFECT; DRUG CHOICE; ELECTROENCEPHALOGRAM; GENERALIZED EPILEPSY; HUMAN; LONG TERM CARE; MYOCLONUS; MYOCLONUS EPILEPSY; OUTCOME ASSESSMENT; PHOTOSENSITIVITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; REVIEW; RISK ASSESSMENT; SOCIAL ASPECT; TREATMENT DURATION; TREATMENT WITHDRAWAL; ADOLESCENT; COMPARATIVE STUDY; DIET THERAPY; ELECTROENCEPHALOGRAPHY; METHODOLOGY; NEUROLOGIC EXAMINATION; STATISTICS; SYNDROME; TREATMENT OUTCOME;

ADOLESCENT; ANTICONVULSANTS; CHILD; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; EPILEPSY, GENERALIZED; HUMANS; MYOCLONIC EPILEPSY, JUVENILE; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; SYNDROME; TREATMENT OUTCOME; VALPROIC ACID;

EID: 32944472435     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2005.00322.x     Document Type: Review

References (36)

1. Camfield PR, Camfield CS, Wirrell E. Idiopathic generalized epilepsy (IGE) beginning in childhood - how many patients are there, which syndromes and what happens in the long run? Insights from the Nova Scotia population-based study. Epilepsia 2004;45:(Suppl 7):S365.
2. Berg AT, Levy SR, Testa FM, et al. Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement. Epilepsia 1999;40:439-44.
3. Camfield PR, Camfield CS. Childhood epilepsy: what is the evidence for what we think and what we do? J Child Neurol 2003;18:272-87.
4. Andermann F Berkovic SF. Idiopathic generalized epilepsy with generalized and other seizures in adolescence. Epilepsia 2001;42:317-20.
5. Van Donselaar CA, Geerts AT, Meulstee J, et al. Reliability of the diagnosis of a first seizure. Neurology 1989;39:267-71.
6. Rugg-Gunn FJ, Harrison NA, Duncan JS. Evaluation of the accuracy of seizure descriptions by the relatives of patients with epilepsy. Epilepsy Res 2001;43:193-9.
7. Bodensteiner JB, Brownsworth RD, Knapik JR, et al. Interobserver variability in the ILAE classification of seizures in childhood. Epilepsia 1988;29:123-8.
8. Parra J, Augustijn PB, Geerts Y, et al. Classification of epileptic seizures: a comparison of two systems. Epilepsia 2001;42:476-82.
9. Wirrell EC, Camfield CS, Camfield PR, et al. Long-term prognosis of typical childhood absence epilepsy. Neurology 1996;47:912-8.
10. King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998;352:1007-11.
11. Hirtz D, Berg A, Bettis D, et al. Practice parameter: the evaluation of a first nonfebrile seizure in children (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:616-23.
12. Camfield CS, Camfield PR, Smith E, et al. Asymptomatic children with epilepsy: little benefit from screening for anticonvulsant-induced liver, blood or renal damage. Neurology 1986;36:838-41.
13. Camfield PR, Camfield CS, Dooley J, et al. Routine screening of blood and urine for severe reactions to anticonvulsant drugs in asymptomatic patients is of doubtful value. Can Med Assoc J 1989;140:1303-5.
14. Trudeau V, Myers S, LaMoreaux L, et al. Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 1996;11:470-5.
15. Sato S, White BG, Penry JK, et al. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 1982;32:157-63.
16. Callaghan N, O'Hare J, O'Driscoll D, et al. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol 1982;24:830-6.
17. Coppola G, Auricchio G, Federico R, et al. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized parallel-group study. Epilepsia 2004;45:1048-53.
18. Genton P, Gelisse P, Thomas P, et al. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000;5:1106-9.
19. Carrazana EJ, Wheeler SD. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2001;56:1424-5.
20. Camfield PR, Gordon K, Camfield CS, et al. EEG results are rarely the same if repeated within six months in childhood epilepsy. Can J Neurol Sci 1995;22:297-300.
21. Aldenkamp AP, Arends J. Effects of epileptiform EEG discharges on cognitive function: is the concept of "transient cognitive impairment still valid? Epilepsy Behav 2004;5(Suppl 1):S25-34.
22. Aldenkamp A, Arends J. The relative influence on epileptiform EEG discharges, short nonconvulsive seizures, and type of epilepsy on cognitive function. Epilepsia 2004;45:54-60.
23. Kasteleijin-Nolst Trenite DG. Transient cognitive impairment during subclinical epileptiform electroencephalographic discharges. Semin Pediatr Neurol 1995;2:246-53.
24. Wirrell EC, Camfield PR, Camfield CS, et al. Will a critical level of hyperventilation-induced hypocapnia always induce an absence seizure? Epilepsia 1996;37:459-62.
25. Wirrell E, Camfield PR, Camfield CS, et al. Accidental injury is a serious risk in children with typical absence epilepsy. Arch Neurol 1996;53:929-32.
26. de Feo MR, Mecarelli O, Ricci G, et al. The utility of ambulatory EEG monitoring in typical absence seizures. Brain Dev 1991;13:223-7.
27. Harding W, Jeavons J, Photosensitive Epilepsy. London: MacKeith Press, 1992:pp. 125-50.
28. Camfield PR, Camfield CS, Dooley JM, et al. Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double blind controlled study. Neurology 1992;42:1000-3.
29. Camfield CS for the Commission of Pediatrics of the International League against Epilepsy. Restrictions for children with epilepsy. Epilepsia 1997;38:1054-7.
30. Frucht MM, Quigg M, Schwaner C, et al. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 2000;41:1534-9.
31. Gordon E, Devinsky O. Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia 2001;42:1266-72.
32. Wirrell E, Camfield CS, Camfield PR, et al. Long-term psychosocial outcome in typical absence epilepsy: sometimes a wolf in sheep's clothing. Arch Pediatr Adolesc Med 1997;151:152-8.
33. Dooley JM, Gordon K, Camfield PR, et al. Discontinuation of anticonvulsant therapy in children free of seizures for 1 year. Neurology 1996;46:969-74.
34. Bartolomei F, Roger J, Bureau M, et al. Prognostic factors for childhood and juvenile absence epilepsies. Eur Neurol 1997;37:169-75.
35. Loiseau P, Douche B, Pedespan JM. Absence epilepsies. Epilepsia 1995;36:1182-6.
36. Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 1994;35:285-96.